The obtained binding curves using SCORE provide detailed information on kinetics and thermodynamics of the observed interaction(s) as well as on concentrations of the used analytes.
These data can be relevant for pharmaceutical screening and drug design, biosensors and other biomedical applications, diagnostics, and cell-based assays.
Binding of specific ligands to the immobilised receptor molecules results in a change refractive index n and physical thickness d of the sensitive layer.
The SCORE technology was commercialised by Biametrics GmbH, a service provider and instrument manufacturer with headquarters in Tübingen, Germany.
In January 2020, Biametrics GmbH and its technology was acquired by BioCopy Holding AG, headquartered in Aadorf, Switzerland.